Peptide-Based Vaccine against Breast Cancer: Recent Advances and Prospects

Breast cancer is considered the second-leading after lung and most prevalent among women globally. Currently, immunotherapy via vaccine has gained great attention due to specific targeted immune cell activity that creates a potent response, thus providing long-lasting protection against disease. Despite peptides being very susceptible enzymatic degradation poor immunogenicity, they can be easily customized with selected epitopes induce response particulate carriers improve their delivery overcome weaknesses. With advances in nanotechnology, peptide-based could incorporate other components, thereby modulating system breast cancer. Considering vaccines seem show remarkably promising outcomes cancer, this review focuses on provides view of used Here, we discuss benefits associated vaccine, which mainstay prevention recurrence Additionally, also report results recent trials as well plausible prospects for nanotechnology